2CA-15640-85391
5 vaccinations
5 coded responses
42 check-ins
5 free-text entries
0 call cases
- Sex
- Male
- Age at first dose
- 66+
- ZIP prefix
- 145 / NY
- Registered
- 2021-01-29
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-01-29
Registered in v-safe
-
2021-01-29
Dose 1 — Pfizer-BioNTech
- 2021-01-30
- 2021-01-31
- 2021-02-01
- 2021-02-02
- 2021-02-03
- 2021-02-04
- 2021-02-06
- 2021-02-12
-
2021-02-19
Dose 2 — Pfizer-BioNTech
- 2021-02-19
-
2021-02-20
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Headache, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
- 2021-02-21
- 2021-02-22
- 2021-02-23
- 2021-02-24
- 2021-02-25
- 2021-02-26
- 2021-03-05
- 2021-03-12
- 2021-03-19
- 2021-03-26
- 2021-04-02
- 2021-05-21
-
2021-08-20
Survey response — 6 months, dose 2MedDRA: Nasopharyngitis — Feeling: Good · Be unable to do your normal daily activitiesFree text: Summer cold.MedDRA releases: 2021-09,2024-11 · check-in free text available
-
2021-09-27
Dose 3 — Pfizer-BioNTech
- 2021-10-01
- 2021-10-02
- 2021-10-03
- 2021-10-04
- 2021-10-11
-
2021-10-18
Survey response — day 21, dose 3MedDRA: Fatigue, Headache, Nasopharyngitis — Feeling: GoodFree text: Mild cold symptoms, headache, fatigue.MedDRA releases: 2024-11 · check-in free text available
- 2021-10-25
- 2021-11-01
- 2021-11-08
- 2021-12-27
-
2022-03-28
Survey response — 6 months, dose 3MedDRA: Body temperature increased, Fatigue, Illness, Nasopharyngitis, Pain, SARS-CoV-2 test negative — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: 2 distinct illnesses 1. 7-10 days of severe body aches and fatigue. Did not test for COVID. 2. Severe head cold with fever of 100.2 for 1-2 days, cold symptoms persisting for 11 to 12 days with gradual improvement. Home Covid test negative.MedDRA releases: 2024-11 · check-in free text available
-
2022-04-19
Dose 4 — Pfizer-BioNTech
- 2022-05-17
- 2022-05-24
- 2022-05-31
- 2022-07-19
-
2022-09-06
Dose 5 — Moderna
-
2022-10-12
Survey response — day 35, dose 5MedDRA: Fatigue, Nasopharyngitis, Throat irritation — Feeling: FairFree text: Mild cold symptoms, fatigue, scratchy throatMedDRA releases: 2024-11 · check-in free text available
- 2022-10-20
-
2022-12-06
Survey response — 3 months, dose 5MedDRA: COVID-19, Chills, Malaise, Pyrexia, Respiratory tract congestion — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: Covid. High fever and chills for one day. Felt lousy with lower fever for 3 more days, but a little better each day. Lingering congestion and fatigue for two plus weeks. Tested negative after two weeks. Now fully recovered.MedDRA releases: 2024-11 · check-in free text available
- 2023-03-12
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-29 | Pfizer-BioNTech | |
| 2 | 2021-02-19 | Pfizer-BioNTech | |
| 3 | 2021-09-27 | Pfizer-BioNTech | No |
| 4 | 2022-04-19 | Pfizer-BioNTech | No |
| 5 | 2022-09-06 | Moderna | No |
Free text
Release 9 — 6 months, dose 2
Symptoms: Summer cold.
Release 10 — day 21, dose 3
Symptoms: Mild cold symptoms, headache, fatigue.
Release 11 — 6 months, dose 3
Symptoms: 2 distinct illnesses 1. 7-10 days of severe body aches and fatigue. Did not test for COVID. 2. Severe head cold with fever of 100.2 for 1-2 days, cold symptoms persisting for 11 to 12 days with gradual improvement. Home Covid test negative.
Release 12 — day 35, dose 5
Symptoms: Mild cold symptoms, fatigue, scratchy throat
Release 12 — 3 months, dose 5
Symptoms: Covid. High fever and chills for one day. Felt lousy with lower fever for 3 more days, but a little better each day. Lingering congestion and fatigue for two plus weeks. Tested negative after two weeks. Now fully recovered.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Body temperature increased | · | · | ✓ |
| SD | Chills | · | · | ✓ |
| SD | COVID-19 | · | · | ✓ |
| SD | Fatigue | · | · | ✓ |
| SD | Headache | · | · | ✓ |
| SD | Illness | · | · | ✓ |
| SD | Malaise | · | · | ✓ |
| SD | Nasopharyngitis | ✓ | · | ✓ |
| SD | Pain | · | · | ✓ |
| SD | Pyrexia | · | · | ✓ |
| SD | Respiratory tract congestion | · | · | ✓ |
| SD | SARS-CoV-2 test negative | · | · | ✓ |
| SD | Throat irritation | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release